Cyclo Therapeutics Achieves Landmark Milestone with Completi

Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1

Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Caroline Hastings , Exchange Commission , Company Transport , Company Trappsol , Nasdaq , Rafael Holdings Inc , Global Principal Investigator For The Company , Cyclo Therapeutics Inc , Health Authorities , Cyclo Therapeutics , Paediatric Investigational Plan , Chief Executive Officer , Global Principal Investigator , Rafael Holdings , Joshua Fine , Chief Financial Officer , Orphan Drug Designation , Fast Track , Rare Pediatric Disease Designations , Rare Pediatric Disease Designation , Priority Review Voucher , Expanded Access ,